China sets lowest growth target on record at 4.5% to 5%. War powers vote fails in the U.S. Senate. Iran targets Amazon's ...

Okta's first-quarter guidance came up short of analyst expectations. The company expects revenue to range between $749 ...

Broadcom's AI revenue jumped 106% as the company continues to be a big beneficiary of the boom in infrastructure spending.

Stocks rebounded on Wednesday, buoyed by gains in technology and semiconductor giants. Oil prices stabilized after this ...

South Korea's Kospi jumped over 12% Thursday, staging a sharp rebound from its worst session, and on course to clock its best ...

The Foundation for Angelman Syndrome Therapeutics (FAST) has helped redefine the role of advocacy groups. Founded and led by ...

The science behind rare disease treatments is advancing at an unprecedented pace. Biogen is sharpening its long-term strategy ...

Sarepta has come under scrutiny over Elevidys, its gene therapy for Duchenne Muscular Dystrophy (DMD). With a one-time ...

As scientific and political pressures collide at the FDA, regulatory bottlenecks are intensifying. At this critical and ...

Personalized therapies, faster diagnoses, and a renewed and previously unimaginable sense of hope for rare disease families.

Attorney General Pam Bondi "claims the DOJ has released all of the Epstein files. The record is clear: they have not," Rep.

The father of Jonathan Gavalas accused Google of convincing his son to commit suicide after first encouraging him to execute ...